Skip to main content
NORTHEAST PHARMACEUTICAL GROUP CO.,LTD logo

NORTHEAST PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 000597 ISIN · CNE0000009G0 LEI · 300300HX6JTMOEENF158 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,606 across all filing types
Latest filing 2021-12-06 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000597

About NORTHEAST PHARMACEUTICAL GROUP CO.,LTD

https://www.nepharm.com.cn

Northeast Pharmaceutical Group Co., Ltd. (NEPG) specializes in the research, development, manufacture, and distribution of active pharmaceutical ingredients (APIs) and finished dosage forms. The company operates as a large-scale integrated pharmaceutical enterprise with a diverse product portfolio encompassing vitamins, antibiotics, cardiovascular agents, and digestive system medications. NEPG is recognized as a global leader in the production of Vitamin C and Vitamin B1, alongside significant output in caffeine and fosfomycin. Its manufacturing facilities adhere to international quality standards, including Good Manufacturing Practice (GMP) certifications. The company serves a broad international market, exporting products to numerous countries while maintaining a strong domestic presence. NEPG focuses on technological innovation and industrial scaling to provide high-quality chemical raw materials and pharmaceutical preparations for global healthcare needs.

Recent filings

Filing Released Lang Actions
关于参加辽宁辖区上市公司投资者网上集体接待日的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement about the company's participation in an online investor collective reception day, including details about the event date, platform, and topics to be discussed. It does not contain financial statements, detailed financial data, or a report itself. It is an announcement related to investor relations and communication rather than a formal report or filing. Given the content and length (487 characters), it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-12-06 Chinese
关于控股子公司被申请清算的进展公告
Legal Proceedings Report Classification · 95% confidence The document is an announcement from Dongbei Pharmaceutical Group Co., Ltd. regarding the progress of a compulsory liquidation application for its holding subsidiary, Dongyao Wuhai Chemical Co., Ltd. It includes details about the court decision, involved parties, company information, and financial impact. The document is relatively short (1479 characters) and serves as a regulatory announcement about a legal proceeding affecting the company. It does not contain full financial statements or detailed financial analysis, nor is it a report or presentation. It is not a certification or a voting result announcement. The content fits best under Legal Proceedings Report (LTR) as it updates on a significant legal matter involving the company.
2021-12-01 Chinese
关于公司董事长、高级管理人员增持公司股票及增持计划的提示性公告
Director's Dealing Classification · 95% confidence The document is a public announcement regarding the increase in shareholdings by the company's chairman and senior management. It details the names of the individuals, their shareholdings before and after the increase, the purpose of the increase, the amount and price range, the method of purchase, and the implementation period. It also discusses compliance with relevant laws and regulations and the risk factors related to the share increase. There are no financial statements or detailed financial performance data. The document is a notification of insider share transactions by directors and senior executives, which fits the definition of Director's Dealing (DIRS). The document length is 2152 characters, which is consistent with a typical announcement of this nature rather than a full report or regulatory filing. Therefore, the appropriate classification is DIRS with high confidence.
2021-11-29 Chinese
关于股东部分股份解除质押及再质押的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the pledge and release of shares by a company shareholder. It details the number of shares pledged and released, the shareholders involved, and related dates. There is no financial statement, earnings data, or management discussion. The document is a regulatory announcement about share pledge status, which fits the category of a Regulatory Filing (RNS) as it does not fit into more specific categories like share issue, director dealings, or capital updates. The document length is about 2000 characters, typical for such announcements.
2021-11-29 Chinese
关于全资子公司获得政府补助的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (1323 characters) about a government subsidy received by a wholly owned subsidiary of the company. It details the amount, the nature of the subsidy, accounting treatment, and impact on profit. There are no financial statements or comprehensive financial data presented. The document is an announcement of a specific event related to government grants, not a full financial report or audit. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is a regulatory announcement informing shareholders and the market about the receipt of government subsidies and related accounting treatment. Therefore, it best fits the category of Regulatory Filings (RNS), which is a fallback for miscellaneous regulatory announcements that do not fit other categories.
2021-11-24 Chinese
关于完成董事会、监事会换届选举及聘任高级管理人员、证券事务代表的公告
Board/Management Information Classification · 100% confidence The document is an announcement from a company about the completion of the board of directors and supervisory board re-election, as well as the appointment of senior management and securities affairs representatives. It details the composition of the new board, committees, supervisory board, and senior management personnel, including their qualifications and backgrounds. There is no financial data or financial performance information presented. The document is a formal disclosure of changes in the company's board and senior management structure. Therefore, it fits the category of Board/Management Information (MANG). The document length is substantial and contains detailed personnel information, not just a brief announcement or a report publication notice.
2021-11-17 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.